Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation - Outstanding Awards and Exercises (Details)

v3.25.1
Stock-Based Compensation - Outstanding Awards and Exercises (Details)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended
Mar. 31, 2025
USD ($)
$ / shares
shares
Awards | Common stock, all series  
Compensation cost not yet recognized  
Shares reserved for future issuance upon exercise of stock options 2,700
Employee Stock Option  
Options  
Options granted (in shares) 0
Compensation cost not yet recognized  
Unrecognized compensation cost options | $ $ 16
Period over which unrecognized compensation cost will be recognized 1 year 3 months 18 days
Employee Stock Option | Series A common stock  
Options  
Outstanding ending balance (in shares) 0
Employee Stock Option | Series B common stock  
Options  
Outstanding ending balance (in shares) 13
Number of awards exercisable (in shares) 13
Expired 83
WAEP  
WAEP Outstanding ending balance (in dollars per share) | $ / shares $ 100.19
WAEP options expired | $ / shares $ 93.13
Options additional disclosures  
Weighted average remaining contractual life outstanding 10 months 24 days
Aggregate intrinsic value outstanding | $ $ 0
Employee Stock Option | Series C common stock  
Options  
Outstanding beginning balance (in shares) 2,649
Exercised (in shares) (7)
Outstanding ending balance (in shares) 2,642
Number of awards exercisable (in shares) 2,415
WAEP  
WAEP Outstanding beginning balance (in dollars per share) | $ / shares $ 120.8
WAEP options exercised (in dollars per share) | $ / shares 77.39
WAEP Outstanding ending balance (in dollars per share) | $ / shares 120.91
WAEP options exercisable (in dollars per share) | $ / shares $ 124.99
Options additional disclosures  
Weighted average remaining contractual life outstanding 3 years 3 months 18 days
Weighted average remaining contractual life exercisable 3 years 1 month 6 days
Aggregate intrinsic value outstanding | $ $ 9
Aggregate intrinsic value exercisable | $ $ 7